MedPath

Merozan 500mg powder for solution for injection or infusion

Registration Number: MAL17055015AZ

Approved
Approval ID

18019e1ee614f367

Registration Number

MAL17055015AZ

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types2 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (2)

10vial VialsAvailable
Package Size: 10vial Vials
Status: NPRA Approved
1vial VialsAvailable
Package Size: 1vial Vials
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

MEROPENEM TRIHYDRATEActive
Monograph: meropenem trihydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Merozan 500mg powder for solution for injection or infusion - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform